Heparinized blood provides equivalent results to EDTA in the CEDIA and FPIA cyclosporine immunoassays, thus facilitating routine cyclosporine determination

Clinica Chimica Acta

Volumn 390, Issue 1-2, 2008, Pages 138-140

  Korte, Wolfgang C ^a   Engler, Hanna ^a   Aldebert, Eva ^a   Riesen, Walter F ^a  

^a Institute for Clinical Chemistry and Haematology   (Switzerland)

Author keywords

CEDIA; Cyclosporine; EDTA blood; FPIA; Heparinized blood

Indexed keywords

CYCLOSPORIN A; EDETIC ACID; HEPARIN;

ANTICOAGULATION; ARTICLE; BLOOD SAMPLING; COMPARATIVE STUDY; DEVICE; DRUG DETERMINATION; FLUORESCENCE POLARIZATION IMMUNOASSAY; HUMAN; PRIORITY JOURNAL;

CYCLOSPORINE; EDETIC ACID; HEPARIN; HUMANS; IMMUNOASSAY;

EID: 39749184654     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2007.12.021     Document Type: Article

References (11)

1. Schutz E., Svinarov D., Shipkova M., et al. Cyclosporin whole blood immunoassays (AxSYM, CEDIA, and Emit): a critical overview of performance characteristics and comparison with HPLC. Clin Chem 44 (1998) 2158-2164
2. Yatscoff R.W., Copeland K.R., and Faraci C.J. Abbott TDx monoclonal antibody assay evaluated for measuring cyclosporine in whole blood. Clin Chem 36 (1990) 1969-1973
3. Prasad R., Maddux M.S., Mozes M.F., Biskup N.S., and Maturen A. A significant difference in cyclosporine blood and plasma concentrations with heparin or EDTA anticoagulant. Transplantation 39 (1985) 667-669
4. Potter J.M., and Self H. Cyclosporin A: variation in whole blood levels related to in vitro anticoagulant usage. Ther Drug Monit 8 (1986) 122-123
5. Critical issues in cyclosporine monitoring: report of the Task Force on Cyclosporine Monitoring. Clin Chem 33 (1987) 1269-1288
6. Loor R., Pope L., Boyd R., Wood K., and Bodepudi V. Monitoring cyclosporine of pre-dose and post-dose samples using nonextraction homogeneous immunoassay. Ther Drug Monit 26 (2004) 58-67
7. Butch A.W., and Fukuchi A.M. Analytical performance of the CEDIA cyclosporine PLUS whole blood immunoassay. J Anal Toxicol 28 (2004) 204-210
8. Shaw L.M., Holt D.W., Keown P., Venkataramanan R., and Yatscoff R.W. Current opinions on therapeutic drug monitoring of immunosuppressive drugs. Clin Ther 21 (1999) 1632-1652 discussion 1631
9. Murthy J.N., Yatscoff R.W., and Soldin S.J. Cyclosporine metabolite cross-reactivity in different cyclosporine assays. Clin Biochem 31 (1998) 159-163
10. Roberts N.B., Dutton J., Higgins G., and Allars L. Evaluation of a novel semi-automated HPLC procedure for whole blood cyclosporin A confirms equivalence to adjusted monoclonal values from Abbott TDx. Clin Chem Lab Med 43 (2005) 228-236
11. Taylor P.J. Therapeutic drug monitoring of immunosuppressant drugs by high-performance liquid chromatography-mass spectrometry. Ther Drug Monit 26 (2004) 215-219